Cancer is still among the top public health enemies of India. Every year, around a few lakhs of new cancer patients are reported, largely in the later stages of cancer when treatment is complicated and costly. Amongst the most common cancer types, breast, cervical, oral, and lung cancers have high mortality rates, especially in remote areas and among marginalised groups, where even a specialist visit or advanced imaging may be a distant dream.
In this situation, the advent of artificial intelligence (AI) was not regarded as some distant prospect but rather as a real-time solution to help fill the most pressing gaps. AI tools have the ability to analyse medical images, identify the smallest changes that even the human eye is unable to see, prioritising the high-risk patients by a second review, and allow the local screening facilities with no or very little infrastructure. India has come a long way from a handful of pilot projects here and there to a more institutionalised national endeavour that involves not only government missions and regulatory framework but also the academic knowledge and private-sector solutions. As a matter of fact, the results of these combined measures are already visible in the first few months of the year 2026 in the form of how technology can improve early detection and make it more affordable and available to a greater number of people.
Government Initiatives Driving AI Adoption
The biggest recent move was the introduction of the Cancer AI & Technology Challenge (CATCH) Grant Program in March 2026, which is a part of the India AI Mission. The Ministry of Electronics and Information Technology (MeitY), along with the National Cancer Grid (NCG) are the driving forces behind this. The program is open for joint proposals from hospitals, research institutions, and technology firms to create AI tools that can help in every aspect of cancer care – especially in screening and early detection.
Many innovative projects have been supported so far under CATCH. DeepTek is developing a method of more accurately analysing chest imaging for earlier diagnosis of lung cancer. Other winners are working on neuro-oncology workflows, breast cancer screening tools like MAMMO-Q, and cervical cancer solutions that bring molecular-level insights to point-of-care settings.
Grants of up to 1 crore are assisting these innovative ideas in making real-world pilots within the NCG’s network of leading cancer centres. Meanwhile, the Strategy for AI in Healthcare in India (SAHI) accompanies this as it lays down the ethical standards and provides a roadmap for the responsible use of AI. Besides, the government has rolled out benchmarking frameworks for health AI and has also embedded AI tools in the Ayushman Bharat Digital Mission for smooth data sharing and referral systems through the National NCD Portal. This makes sure that AI solutions do not function in isolation but rather are interconnected with the existing public health infrastructure.
State-Level Experiments and Pilot Projects
Some states are accelerating their efforts even more. In fact, Goa has become the first state in the country to launch an AI-driven pilot for lung cancer screening. The initiative was announced in February 2026.
The plan is to analyze over 200,000 chest X-rays by the end of the year. The AI system identifies potential abnormalities automatically, thus enabling radiologists to prioritize cases and make diagnoses faster.
In Punjab, ultra-portable AI devices, which are radiation-free for breast and cervical cancer screening methods, were rolled out in several districts. These devices aim at conducting hundreds of screenings daily moreover, in collaboration with ACT Grants and other partners, Punjab is also using the Thermalytix (thermal imaging-based breast cancer solution) and Smart Scope (an instrument for cervical screening) at the community level. This initiative helps in reducing dependency on high-end equipment and specialist doctors.
Academic institutions also have a part to play. For instance, oral cancer screening through AI-based mobile apps that analyse photos and use other methods such as low-cost breath analysers and AI-assisted microscopes for early detection have been developed by the researchers of the Indian Institute of Science and various IITs. These are significant contributions as oral cancer caused by tobacco use continues to be a major health problem in India.
Specific Applications Across Common Cancers
AI is playing an important role in cancer types whose diagnosis relies heavily on images or visual observations. Breast cancer is one of the examples where Thermalytix and other similar computer-aided detection tools use thermography- an effective, radiation-free, non-invasive method along with AI-assisted pattern recognition, to detect abnormalities. It is a wonderful helping hand in the remoteness of Indian villages where women do not go for mammography due to various reasons like cost, discomfort, non-availability of the facilities, etc.
In the case of cervical cancer, visual examination enhanced with AI and automated processing of Pap smears or HPV tests are making the diagnosis more precise and lessening the workload of pathologists. Some of these technologies do not even require an internet connection and can be operated on smartphones, making them amenable to fieldwork by ASHA workers.
In the diagnostic imaging of cancer, AI can analyse chest X-rays to find lung nodules that radiologists might miss. Besides, AI is helping to decide disease severity, choosing those who require more intensive follow-up, and even giving support in pathology slide interpretation. The intention is not to replace doctors but to be a knowledgeable helper who notices things that may be overlooked in busy medical practice.
Regulatory Safeguards and Ethical Considerations
The Central Drugs Standard Control Organisation (CDSCO), recognising the potential hazards of AI in cancer detection and diagnosis, has put such software under Class C medical devices. This is to say that such tools will have to be tested for safety, clinical performance and be constantly monitored just like other high-risk medical technologies.
The SAHI approach is based on transparency, bias elimination and data security. Since AI models are trained on existing data there is a deliberate attempt to include the diverse Indian population in the training dataset so that the AI works well in different regions, genders and people from different socio-economic groups. Algorithmic bias and explainability (so doctors know why a particular case was highlighted) are two of the main issues that are also being worked on.
Challenges on the Path Forward
In spite of the ongoing progress, a number of obstacles still lie ahead. For example, the availability of high-quality, annotated datasets for Indian patients remains quite limited.
Many AI-based innovations will need to be thoroughly validated locally before they can be relied on at a broad level. Besides these issues, the integration of AI tools into existing hospital systems, the training of healthcare workers, and the availability of stable internet connections in rural areas, all represent major logistical challenges.
The cost factor is quite significant, too. Even though some of the solutions are conceptualised as low-cost, their wide-scale adoption would need continuous funding, collaborations between the public and private sectors, and well-defined reimbursement channels through programs such as Ayushman Bharat.
Besides technology, there is a human factor as well. For instance, doctors need to be willing to collaborate with AI, and the patients require assurances that the use of technology is ethical. In order to make technology a trusted companion in healthcare, it is vital to start with open and transparent pilot projects and to have outcomes that can be measured.
Looking Ahead: A More Hopeful Picture
2026 is a pivotal year for India. India AI Mission, CATCH grants, state-level pilots, and academic innovation together are producing a strong AI ecosystem for cancer screening. Initial outcomes from diverse projects indicate improved detection rates, reduced diagnostic delays, and enhanced operations in neglected areas.
The main goal is quite ambitious but still within our reach: to change the trend from mainly late-stage diagnosis to timely interventions, leading to higher survival rates and reducing the financial burden on families and the healthcare system. Cancer screening will never be just about technology. It involves awareness, treatment availability, and quality follow-up care. But AI is emerging as a key facilitator a tool that can enhance doctors’ work, allow the health workers in communities to do more, and bring quality screening right to the places where it is most needed.
The next few years will measure India’s ability to scale up these hopeful solutions while also keeping safety, equity, and human oversight intact. Should the present rhythm of collaboration and innovation be sustained, AI might become one of the major tools in the country’s battle against cancer, not substituting care, but extending its reach and enhancing its effectiveness for everyone.
